Wall Street Experts
ver. ZuMIgo(08/25)
Harmony Biosciences Holdings, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 682
EBIT TTM (mln): 180
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
| Rok finansowy |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
0 |
6 |
160 |
305 |
438 |
582 |
715 |
| Przychód Δ r/r |
0.0% |
inf% |
2564.6% |
91.2% |
43.4% |
32.9% |
22.8% |
| Marża brutto |
0.0% |
73.7% |
82.6% |
81.8% |
80.9% |
79.2% |
78.1% |
| EBIT (mln) |
-41 |
-146 |
4 |
69 |
120 |
192 |
191 |
| EBIT Δ r/r |
0.0% |
252.1% |
-102.5% |
1768.0% |
74.9% |
59.8% |
-0.6% |
| EBIT (%) |
0.0% |
-2433.8% |
2.3% |
22.5% |
27.4% |
33.0% |
26.7% |
| Koszty finansowe (mln) |
0 |
6 |
28 |
24 |
16 |
24 |
17 |
| EBITDA (mln) |
-41 |
-143 |
14 |
88 |
120 |
231 |
233 |
| EBITDA(%) |
0.0% |
-2380.2% |
8.7% |
28.7% |
27.5% |
39.7% |
32.7% |
| Podatek (mln) |
2 |
6 |
15 |
3 |
-77 |
45 |
46 |
| Zysk Netto (mln) |
-40 |
-158 |
-52 |
35 |
181 |
129 |
145 |
| Zysk netto Δ r/r |
0.0% |
296.1% |
-67.2% |
-166.7% |
424.5% |
-29.0% |
12.9% |
| Zysk netto (%) |
0.0% |
-2636.4% |
-32.5% |
11.3% |
41.4% |
22.1% |
20.4% |
| EPS |
-0.81 |
-2.48 |
-0.91 |
0.6 |
3.07 |
2.17 |
2.56 |
| EPS (rozwodnione) |
-0.81 |
-2.48 |
-0.91 |
0.58 |
2.97 |
2.13 |
2.51 |
| Ilośc akcji (mln) |
49 |
64 |
57 |
58 |
59 |
59 |
57 |
| Ważona ilośc akcji (mln) |
49 |
64 |
57 |
59 |
61 |
60 |
58 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |